DE60018081D1 - Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung - Google Patents

Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung

Info

Publication number
DE60018081D1
DE60018081D1 DE60018081T DE60018081T DE60018081D1 DE 60018081 D1 DE60018081 D1 DE 60018081D1 DE 60018081 T DE60018081 T DE 60018081T DE 60018081 T DE60018081 T DE 60018081T DE 60018081 D1 DE60018081 D1 DE 60018081D1
Authority
DE
Germany
Prior art keywords
oral
pharmaceutical compositions
topical administration
topical
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60018081T
Other languages
English (en)
Other versions
DE60018081T2 (de
Inventor
Tomas Andrysek
Milan Stuchlik
Ales Vrana
Alexandr Jegorov
Josef Stuchlik
Vladimir Matha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivax Pharmaceuticals sro
Original Assignee
Ivax Pharmaceuticals sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60018081(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ivax Pharmaceuticals sro filed Critical Ivax Pharmaceuticals sro
Application granted granted Critical
Publication of DE60018081D1 publication Critical patent/DE60018081D1/de
Publication of DE60018081T2 publication Critical patent/DE60018081T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
DE60018081T 1999-08-17 2000-08-17 Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung Expired - Lifetime DE60018081T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9919288 1999-08-17
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (2)

Publication Number Publication Date
DE60018081D1 true DE60018081D1 (de) 2005-03-17
DE60018081T2 DE60018081T2 (de) 2006-01-05

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60018081T Expired - Lifetime DE60018081T2 (de) 1999-08-17 2000-08-17 Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
DE60322454T Expired - Lifetime DE60322454D1 (de) 1999-08-17 2003-08-17 Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60322454T Expired - Lifetime DE60322454D1 (de) 1999-08-17 2003-08-17 Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung

Country Status (40)

Country Link
US (1) US20070190132A1 (de)
EP (2) EP1210119B1 (de)
JP (2) JP2003507343A (de)
KR (2) KR100828747B1 (de)
CN (2) CN101406453A (de)
AR (2) AR025324A1 (de)
AT (2) ATE402691T1 (de)
AU (1) AU777740B2 (de)
BR (1) BR0013385A (de)
CA (2) CA2452118A1 (de)
CO (1) CO5380014A1 (de)
CY (1) CY1105318T1 (de)
CZ (2) CZ296170B6 (de)
DE (2) DE60018081T2 (de)
DK (2) DK1334717T3 (de)
EE (2) EE04955B1 (de)
EG (1) EG23994A (de)
ES (2) ES2311077T3 (de)
GB (1) GB2355656B (de)
HK (1) HK1049629A1 (de)
HR (1) HRP20020154B1 (de)
HU (1) HUP0203236A3 (de)
IL (4) IL158108A0 (de)
JO (1) JO2324B1 (de)
MX (1) MXPA02001631A (de)
NO (2) NO20020760L (de)
NZ (1) NZ517271A (de)
PE (1) PE20010636A1 (de)
PL (1) PL192769B1 (de)
PT (2) PT1210119E (de)
RU (2) RU2279894C2 (de)
SA (1) SA00210487B1 (de)
SG (1) SG143019A1 (de)
SI (1) SI1210119T1 (de)
SK (2) SK286083B6 (de)
TN (1) TNSN00173A1 (de)
UA (2) UA72539C2 (de)
UY (1) UY26303A1 (de)
WO (1) WO2001012229A1 (de)
ZA (2) ZA200308221B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
EP1935407A1 (de) * 2002-12-03 2008-06-25 Elan Pharma International Limited Formen zur Dosierung einer Flüssigkeit mit geringer Viskosität
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
EP1582206A4 (de) * 2002-12-04 2010-09-22 Nisshin Pharma Inc Wasserlösliche zusammensetzung mit coenzym q10
KR20200083657A (ko) * 2002-12-09 2020-07-08 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
US8236286B2 (en) * 2004-10-20 2012-08-07 Kao Corporation Liquid compositions for the oral cavity
BRPI0608173A2 (pt) * 2005-02-24 2010-11-09 Elan Pharma Int Ltd composição, uso da mesma, e, método de produzir uma composição de docetaxel nanoparticulada ou análogo do mesmo
AU2009319167A1 (en) * 2008-11-28 2010-06-03 Lectio Pharmaentwicklungs-Und Verwertungs Gmbh Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
SI2405892T1 (sl) * 2009-03-12 2013-06-28 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Farmacevtska formulacija, ki obsega ketoprofen in polioksialkilenski ester hidroksimaščobne kisline
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
WO2016160412A1 (en) * 2015-03-27 2016-10-06 Arch Personal Care Products, Lp Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
WO1998040094A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
JP2001515491A (ja) * 1997-03-12 2001-09-18 アボツト・ラボラトリーズ 親油性化合物の投与のための親油性二成分系
BR9811058A (pt) * 1997-07-29 2000-09-05 Upjohn Co Formulação auto-emulsificante para compostos lipofìlicos
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
DE60322454D1 (de) 2008-09-11
EP1210119A1 (de) 2002-06-05
RU2279894C2 (ru) 2006-07-20
JP2003507343A (ja) 2003-02-25
GB2355656B (en) 2004-04-07
JP2004238399A (ja) 2004-08-26
CA2452118A1 (en) 2001-02-22
UY26303A1 (es) 2001-03-16
ES2237443T3 (es) 2005-08-01
GB2355656A (en) 2001-05-02
CO5380014A1 (es) 2004-03-31
SG143019A1 (en) 2008-06-27
UA72539C2 (en) 2005-03-15
PE20010636A1 (es) 2001-06-02
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
EE04955B1 (et) 2008-02-15
SI1210119T1 (en) 2005-06-30
HK1049629A1 (zh) 2003-05-23
US20070190132A1 (en) 2007-08-16
CA2380951C (en) 2010-03-23
NO20020760L (no) 2002-04-16
NO20020760D0 (no) 2002-02-15
EE200300371A (et) 2003-10-15
HUP0203236A3 (en) 2004-06-28
KR20050095651A (ko) 2005-09-29
MXPA02001631A (es) 2003-07-14
SK2482002A3 (en) 2002-12-03
HUP0203236A2 (hu) 2003-01-28
SK286083B6 (sk) 2008-03-05
BR0013385A (pt) 2002-05-07
RU2279895C2 (ru) 2006-07-20
ATE288766T1 (de) 2005-02-15
CN1382061A (zh) 2002-11-27
PL353445A1 (en) 2003-11-17
DE60018081T2 (de) 2006-01-05
EP1334717A3 (de) 2004-01-02
ZA200308221B (en) 2004-09-29
IL148200A (en) 2007-12-03
KR100828748B1 (ko) 2008-05-09
AU777740B2 (en) 2004-10-28
EP1334717A2 (de) 2003-08-13
DK1210119T3 (da) 2005-06-20
PT1210119E (pt) 2005-05-31
NZ517271A (en) 2004-02-27
HRP20020154B1 (en) 2006-07-31
IL158108A0 (en) 2004-03-28
AR043106A2 (es) 2005-07-20
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
HRP20020154A2 (en) 2003-12-31
EP1210119B1 (de) 2005-02-09
IL148200A0 (en) 2002-09-12
DK1334717T3 (da) 2008-11-24
CZ296170B6 (cs) 2006-01-11
ZA200201315B (en) 2004-06-30
GB9919288D0 (en) 1999-10-20
ES2311077T3 (es) 2009-02-01
RU2003133451A (ru) 2005-04-20
AU6461300A (en) 2001-03-13
SA00210487B1 (ar) 2006-09-10
PT1334717E (pt) 2008-10-09
EP1334717B1 (de) 2008-07-30
WO2001012229A1 (en) 2001-02-22
CA2380951A1 (en) 2001-02-22
IL158108A (en) 2010-04-15
JO2324B1 (en) 2005-09-12
TNSN00173A1 (en) 2005-11-10
CZ2002575A3 (cs) 2003-05-14
CN101406453A (zh) 2009-04-15
UA75926C2 (en) 2006-06-15
EE04954B1 (et) 2008-02-15
ATE402691T1 (de) 2008-08-15
EG23994A (en) 2008-03-10
CY1105318T1 (el) 2010-03-03
PL192769B1 (pl) 2006-12-29
AR025324A1 (es) 2002-11-20
NO20034778D0 (no) 2003-10-24
KR20020059367A (ko) 2002-07-12

Similar Documents

Publication Publication Date Title
ATE402691T1 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
NO20003218L (no) Oral farmasøytisk doseringsform med forlenget frigivningsvirkning
DE60317803D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ATA59499A (de) Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
ATE279927T1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
EP1188440A4 (de) Medizinische zusammensetzungen zur oralen verabreichung
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
GB0014474D0 (en) Pharmaceutical formulation and manufacture of oral dosage units
SE9904414D0 (sv) Pharmaceutical composition and use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted